Profile data is unavailable for this security.
About the company
CellSource Co., Ltd. is a Japan-based company engaged in regenerative medicine related business and consumer business. The Company operates in two business segments. The Regenerative Medicine Related business segment is engaged in the provision of contracted services for processing tissues and cells derived from fat and blood to medical institutions, and support services for regenerative medicine laws and regulations related to safety assurance such as regenerative medicine, as well as sales of medical equipment. The Consumer business segment is engaged in the sales of cosmetics and facial products to general consumers.
- Revenue in JPY (TTM)3.71bn
- Net income in JPY10.66m
- Incorporated2015
- Employees148.00
- LocationCellSource Co Ltd11F, Shibuya Cast, 1-23-21, ShibuyaSHIBUYA-KU 150-0002JapanJPN
- Phone+81 364555308
- Fax+81 364555968
- Websitehttps://www.cellsource.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delta-Fly Pharma Inc | 0.00 | -1.65bn | 2.70bn | 13.00 | -- | 7.20 | -- | -- | -162.56 | -162.56 | 0.00 | 30.84 | 0.00 | -- | -- | 0.00 | -352.25 | -88.06 | -490.58 | -97.02 | -- | -- | -- | -1,051.54 | -- | -4,172.58 | 0.00 | -- | -- | -- | -20.41 | -- | -61.24 | -- |
| Perseus Proteomics Inc | 121.95m | -788.76m | 3.48bn | 32.00 | -- | 3.31 | -- | 28.54 | -53.50 | -53.50 | 8.27 | 71.39 | 0.0668 | 1.85 | 10.22 | 3,810,875.00 | -43.18 | -38.61 | -46.14 | -40.75 | 87.27 | 90.16 | -646.80 | -837.30 | 14.76 | -- | 0.00 | -- | 19.89 | 7.02 | 18.08 | -- | 95.88 | -- |
| Muromachi Chemicals Inc | 7.37bn | 364.59m | 4.56bn | 203.00 | 12.43 | 1.69 | 8.44 | 0.6191 | 89.59 | 89.59 | 1,819.39 | 658.42 | 1.23 | 3.81 | 5.84 | 36,304,700.00 | 6.09 | 5.99 | 8.66 | 10.36 | 29.85 | 29.90 | 4.95 | 4.89 | 1.76 | 18.37 | 0.4769 | 26.50 | 4.46 | 4.73 | -26.93 | 50.19 | 32.64 | -- |
| Symbio Pharmaceuticals Ltd | 1.31bn | -4.78bn | 5.57bn | 108.00 | -- | 4.07 | -- | 4.26 | -95.49 | -95.49 | 26.04 | 21.39 | 0.296 | 1.37 | 3.83 | -- | -108.11 | -19.84 | -140.91 | -24.15 | 72.45 | 74.71 | -365.25 | -26.66 | 2.74 | -44.43 | 0.6092 | -- | -46.69 | -15.23 | -24.59 | -- | -11.15 | -- |
| Kohjin Bio Co Ltd | 5.20bn | 719.61m | 6.27bn | 167.00 | 8.72 | 1.08 | 5.71 | 1.21 | 140.79 | 140.79 | 1,017.95 | 1,137.25 | 0.5995 | 3.69 | 5.53 | 31,156,770.00 | 8.29 | -- | 11.44 | -- | 44.58 | -- | 13.83 | -- | 1.61 | -- | 0.2512 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| MEDRx Co Ltd | 121.55m | -1.26bn | 6.71bn | 22.00 | -- | 3.12 | -- | 55.19 | -25.69 | -25.69 | 2.40 | 36.20 | 0.0494 | 0.0538 | 1.82 | 5,525,137.00 | -51.01 | -50.16 | -52.60 | -53.46 | 99.26 | 97.56 | -1,033.29 | -1,068.36 | 30.81 | -180.53 | 0.00 | -- | 773.28 | 8.71 | 13.52 | -- | -74.64 | -- |
| Nippon Chemiphar Co Ltd | 32.52bn | 545.00m | 7.46bn | 855.00 | 11.59 | 0.3296 | 3.64 | 0.2293 | 151.00 | 151.00 | 9,009.80 | 5,309.46 | 0.6233 | 1.98 | 2.75 | 38,035,090.00 | 1.04 | 0.6794 | 1.44 | 0.9686 | 26.19 | 28.43 | 1.68 | 1.04 | 1.34 | -- | 0.4785 | 55.16 | 5.93 | 0.5075 | 263.33 | -7.58 | 32.85 | 0.00 |
| K Pharma Inc | 0.00 | -993.23m | 7.95bn | 17.00 | -- | 6.28 | -- | -- | -85.59 | -85.59 | 0.00 | 109.00 | 0.00 | 0.00 | -- | -- | -37.53 | -- | -38.74 | -- | -- | -- | -- | -- | 28.29 | -1,982.81 | 0.5424 | -- | -- | -- | -17.34 | -- | -- | -- |
| CellSource Co Ltd | 3.71bn | 10.66m | 8.13bn | 148.00 | 819.44 | 1.35 | 38.91 | 2.19 | 0.5003 | 0.5003 | 186.84 | 303.58 | 0.5265 | 5.91 | 11.31 | 25,077,400.00 | 0.1512 | 10.68 | 0.1613 | 11.89 | 56.24 | 64.88 | 0.2872 | 14.37 | 11.79 | 16.09 | 0.0093 | 20.88 | -14.78 | 14.87 | -95.52 | -47.76 | 8.90 | -- |
| COSMO BIO COMPANY, LIMITED | 10.51bn | 243.00m | 8.15bn | 174.00 | 31.62 | 0.8244 | 20.43 | 0.7755 | 42.64 | 42.64 | 1,842.53 | 1,635.05 | 0.891 | 6.52 | 4.02 | 60,419,540.00 | 2.08 | 5.38 | 2.41 | 6.41 | 34.20 | 36.39 | 2.34 | 5.95 | 5.52 | -- | 0.002 | 41.03 | 7.46 | 5.75 | -40.72 | 2.03 | 8.68 | 28.99 |
| Solasia Pharma KK | 326.00m | -1.80bn | 8.35bn | 23.00 | -- | 4.48 | -- | 25.60 | -8.12 | -8.12 | 1.44 | 6.91 | 0.1383 | 0.5431 | 5.67 | 14,173,910.00 | -76.18 | -64.46 | -87.38 | -80.79 | 73.93 | 59.35 | -550.92 | -401.81 | 4.27 | -77.04 | 0.0547 | -- | -48.78 | -24.75 | -74.55 | -- | -73.26 | -- |
| CellSeed Inc | 120.30m | -1.03bn | 11.16bn | 38.00 | -- | 7.98 | -- | 92.80 | -29.71 | -29.71 | 3.47 | 37.83 | 0.0562 | 1.22 | 4.75 | 3,165,816.00 | -48.11 | -45.50 | -51.99 | -49.29 | 52.72 | 57.47 | -856.11 | -478.14 | 7.05 | -- | 0.0949 | -- | 1.65 | -6.87 | -1.57 | -- | 6.39 | -- |
| Wakamoto Pharmaceutical Co Ltd | 9.29bn | 298.60m | 11.29bn | 286.00 | 37.66 | 0.93 | 15.24 | 1.21 | 8.60 | 8.60 | 267.77 | 348.39 | 0.6006 | 1.62 | 3.06 | 32,493,160.00 | 1.93 | -0.0678 | 2.22 | -0.0781 | 47.70 | 48.65 | 3.21 | -0.1246 | 2.42 | -- | 0.0082 | -- | 0.6595 | -6.53 | -40.86 | -- | 21.87 | -- |
Data as of Feb 13 2026. Currency figures normalised to CellSource Co Ltd's reporting currency: Japanese Yen JPY
4.34%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 08 Jan 2026 | 367.20k | 1.85% |
| Amova Asset Management Co., Ltd.as of 09 Jan 2026 | 170.90k | 0.86% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2025 | 164.70k | 0.83% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 2026 | 76.00k | 0.38% |
| BlackRock Japan Co. Ltd.as of 08 Jan 2026 | 22.90k | 0.12% |
| Asset Management One Co., Ltd.as of 08 Jan 2026 | 19.90k | 0.10% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 30 Sep 2025 | 18.00k | 0.09% |
| Sumitomo Mitsui DS Asset Management Co., Ltd.as of 08 Jan 2026 | 9.60k | 0.05% |
| Nissay Asset Management Corp.as of 20 Nov 2024 | 6.70k | 0.03% |
| Norinchukin Zenkyoren Asset Management Co., Ltd.as of 08 Jan 2026 | 4.20k | 0.02% |
More ▼
Data from 30 Sep 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
